World's Rarest Blood Type 'Golden' Could Revolutionize Transfusions
Only a handful of people on the planet have the ultra-rare blood type known as Rh-null, which has earned it the nickname "golden blood." This rare variant lacks all three main ABO and Rh antigens found in other blood types, making it extremely valuable for transfusions.
The American Red Cross considers a blood type rare when it occurs in fewer than 1 in 1,000 people. At around 1 in 6 million, Rh-null takes the top spot as the rarest of them all. To understand why it's so extraordinary, one must first grasp how blood types are classified.
Blood types are determined by antigens - proteins and sugars on red blood cells that signal to the immune system what blood belongs in the body and what doesn't. The two systems most likely to trigger an immune response are ABO and Rhesus (Rh), which together determine one of eight main blood types: A+, A-, B+, B-, AB+, AB-, O+ or O-.
When a person receives transfused blood containing different antigens, their body produces antibodies that can lead to life-threatening reactions. For instance, people with Rh-null blood have no rhD antigen, meaning even a transfusion with O-negative blood can trigger an immune response.
Given its rarity and potential benefits, scientists are racing to grow this elusive blood type in the lab. A breakthrough that could revolutionize blood transfusions worldwide, researchers hope to increase the supply of this golden blood for patients who desperately need it.
Lab-grown Rh-null was first created using the gene-editing technique CRISPR-Cas9 in 2018. However, due to the technology's controversy and strict regulations, widespread use is still years away. Researchers are currently testing lab-grown red blood cells developed from donor stem cells when transfused into humans.
The quest for this golden blood has sparked excitement among scientists. "If we can grow more of it, that would be really exciting," said Dr. Ash Toye, a professor at the University of Bristol. Despite the challenges, researchers remain optimistic about the potential impact on patients with rare Rh blood types who struggle to find compatible donors.
As medical technology advances, the world may one day see an end to this golden blood's scarcity, making it more accessible for those in need.
Only a handful of people on the planet have the ultra-rare blood type known as Rh-null, which has earned it the nickname "golden blood." This rare variant lacks all three main ABO and Rh antigens found in other blood types, making it extremely valuable for transfusions.
The American Red Cross considers a blood type rare when it occurs in fewer than 1 in 1,000 people. At around 1 in 6 million, Rh-null takes the top spot as the rarest of them all. To understand why it's so extraordinary, one must first grasp how blood types are classified.
Blood types are determined by antigens - proteins and sugars on red blood cells that signal to the immune system what blood belongs in the body and what doesn't. The two systems most likely to trigger an immune response are ABO and Rhesus (Rh), which together determine one of eight main blood types: A+, A-, B+, B-, AB+, AB-, O+ or O-.
When a person receives transfused blood containing different antigens, their body produces antibodies that can lead to life-threatening reactions. For instance, people with Rh-null blood have no rhD antigen, meaning even a transfusion with O-negative blood can trigger an immune response.
Given its rarity and potential benefits, scientists are racing to grow this elusive blood type in the lab. A breakthrough that could revolutionize blood transfusions worldwide, researchers hope to increase the supply of this golden blood for patients who desperately need it.
Lab-grown Rh-null was first created using the gene-editing technique CRISPR-Cas9 in 2018. However, due to the technology's controversy and strict regulations, widespread use is still years away. Researchers are currently testing lab-grown red blood cells developed from donor stem cells when transfused into humans.
The quest for this golden blood has sparked excitement among scientists. "If we can grow more of it, that would be really exciting," said Dr. Ash Toye, a professor at the University of Bristol. Despite the challenges, researchers remain optimistic about the potential impact on patients with rare Rh blood types who struggle to find compatible donors.
As medical technology advances, the world may one day see an end to this golden blood's scarcity, making it more accessible for those in need.